ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2020 American Transplant Congress

    Liver Transplantation in Obese Recipients: Post-Transplant Weight Gain and Outcomes

    D. Soma1, Y. Park1, P. Mihaylov1, B. Ekser1, M. S. Ghabril2, M. A. Lacerda2, N. Chalasani2, R. S. Mangus1, C. A. Kubal1

    1Transplant Division, Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, 2Transplant Hepatology, Division of Gastroenterology, Indiana University School of Medicine, Indianapolis, IN

    *Purpose: Non-alcoholic fatty liver disease is now the most common cause of end-stage liver disease necessitating orthotopic liver transplantation (OLT) in the United States. Several…
  • 2020 American Transplant Congress

    Outcome of Hepatitis B Virus DNA-Positive Liver Transplantation in Hepatitis B Virus/Hepatitis D Virus Co-Infected Recipient Treated with High Dose Hepatitis B Immune Globulin: A Case Report

    M. B. Hammami1, M. Haris1, L. Toman1, N. Danis1, B. Saberi2, E. King3, J. Garonzik-Wang3, B. Philosophe3, A. M. Cameron3, A. Gurakar1

    1Gastroenterology and Hepatology, Johns Hopkins, Baltimore, MD, 2Gastroenterology and Hepatology, Icahn School of Medicine at Mount Sinai, New York, NY, 3Transplant Surgery, Johns Hopkins, Baltimore, MD

    *Purpose: Introduction: While common in Asian countries, liver transplantation (LT) for patients with hepatitis B virus (HBV)/hepatitis D virus (HDV) co-infection is rare in the…
  • 2020 American Transplant Congress

    DCD vs DBD Liver Transplantation: Equivalent Charges and Similar Survival- An Effective Expansion of the Donor Pool

    N. Singh, K. Helfrich, M. Alebrahim, C. Akateh, K. Mumtaz, A. Logan, A. Schenk, S. Black, E. Elkhammas, K. Washburn, A. El-Hinnawi

    Ohio State University, Columbus, OH

    *Purpose: The shortage of allografts available for liver transplantation (LT) has prompted the need for expansion of donor pool to include donation after circulatory death…
  • 2020 American Transplant Congress

    Liver Transplant Recipients with BMI 40 to <50 kg/m2 Have Excellent Patient and Graft Survival

    K. Daniel, J. Hause, F. Osman, J. Mezrich, E. Spengler

    University of Wisconsin School of Medicine and Public Health, Madison, WI

    *Purpose: Obesity rates in the United States (US) have reached nearly 40%, which has led to an increasing proportion of liver transplant (LT) candidates with…
  • 2020 American Transplant Congress

    Public Health Insurance is Associated with Reduced Access to Living Donor Liver Transplantation and Increased Liver Transplant Waiting List Mortality: An Analysis of the SRTR

    R. Hogen1, M. Aljehani2, J. Lee3, L. Sher1, Y. Genyk1, J. Emamaullee1

    1Surgery, Division of Hepatobiliary and Abdominal Organ Transplant Surgery, University of Southern California, Los Angeles, CA, 2Surgery, University of Southern California, Los Angeles, CA, 3Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California, Los Angeles, CA

    *Purpose: Living donor liver transplantation (LDLT) is associated with improved survival and lower hospital costs, but it continues to makes up less than 5% of…
  • 2020 American Transplant Congress

    National Trends in Locoregional Therapy among Liver Transplant (LT) Candidates with Hepatocellular Carcinoma (HCC) in the United States

    A. Kwong1, W. Kim1, F. Yao2, N. Mehta2

    1Stanford University, Redwood City, CA, 2University of California, San Francisco, San Francisco, CA

    *Purpose: Advances in locoregional therapy (LRT) have expanded treatment options for patients with HCC. As recent policy changes in the United States (US) have lengthened…
  • 2020 American Transplant Congress

    Does Choice of Inferior Vena Cava Reconstruction Technique Have an Impact on the Short and Long Term Postoperative Renal Function in Liver Transplant Recipient?

    S. Chartier-Plante1, S. Asrani2, J. Bayer2, H. Fernandez2, A. Gupta2, E. Martinez2, G. J. Mckenna2, N. Onaca2, N. Onaca2, R. M. Ruiz2, G. Saracino2, A. Wall2, G. Testa2

    1Vancouver General Hospital, Vancouver, BC, Canada, 2Baylor University Medical Center, Dallas, TX

    *Purpose: Postoperative acute kidney injury (AKI) is common after liver transplant (Oltx). It is associated with increased morbidity and mortality and is a risk factor…
  • 2020 American Transplant Congress

    Assessing Immunosuppression with Immunological Testing and Surveillance Biopsies Late after Liver and Intestine Transplantation (LT, IT)

    L. Remaley, R. Falik, K. Soltys, G. Bond, J. Winnier, P. Kachmar, C. Ashokkumar, A. Ganoza, A. Kepler, A. Khanna, J. Squires, P. McKiernan, J. Rudolph, F. Alissa, G. Mazariegos, R. Sindhi

    Pediatric Transplant, Pittsburgh, PA

    *Purpose: Assessing adequacy of immunosuppression is essential during late allograft surveillance after LT or IT.*Methods: To explain why allograft function tests can be normal despite…
  • 2020 American Transplant Congress

    Liver Transplant with Donation after Cardiac Death versus Donation after Brain Death Donors: Survival and Outcomes at 10 Years

    O. Haque1, E. Roth2, A. Fleishman1, K. Khwaja1

    1Surgery, Beth Israel Deaconess Medical Center, Boston, MA, 2Harvard Medical School, Boston, MA

    *Purpose: This observational study utilizes the SRTR database to assess liver transplant outcomes after Donation after Cardiac Death (DCD) versus Donation after Brain Death (DBD)…
  • 2020 American Transplant Congress

    CEACAM1 / ASK1 / p38 Signaling Axis Alleviates Peri-Transplant Liver Injury: From Mouse-to-Human

    H. Hirao1, K. Nakamura2, S. Kageyama1, T. Ito1, K. Kadono1, H. Kojima1, K. J. Dery1, S. Younan1, R. W. Busuttil1, F. M. Kaldas1, J. Kupiec-Weglinski1

    1UCLA, Los Angeles, CA, 2Kyoto University, Kyoto, Japan

    *Purpose: Although CEACAM1 (CM1; carcinoembryonic antigen-related cell adhesion molecule 1; CD66a) regulates hepatic metabolic homeostasis, its role in orthotopic liver transplantation (OLT) remains unknown. A…
  • « Previous Page
  • 1
  • …
  • 66
  • 67
  • 68
  • 69
  • 70
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences